KRAS and neoplasm: We used the cancer-type specific genes (IDH1, PTEN, TP53, KRAS, AC008575.1, APC) in TOOme (He et al., 2020b) to evaluate the performance of somatic mutations detected in tissue or ctNDA for identifying the tumor tissue origin.